    <SEC-DOCUMENT>0000950170-25-052088-index.html : 20250408
    <SEC-HEADER>0000950170-25-052088.hdr.sgml : 20250408
    <ACCEPTANCE-DATETIME>20250408162504
    ACCESSION NUMBER:		0000950170-25-052088
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250408
    DATE AS OF CHANGE:		20250408
    EFFECTIVENESS DATE:		20250408

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			REGENXBIO Inc.
    		CENTRAL INDEX KEY:			0001590877
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				471851754
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37553
    		FILM NUMBER:		25822293

    	BUSINESS ADDRESS:
    		STREET 1:		9804 MEDICAL CENTER DRIVE
    		CITY:			ROCKVILLE
    		STATE:			MD
    		ZIP:			20850
    		BUSINESS PHONE:		240-552-8181

    	MAIL ADDRESS:
    		STREET 1:		9804 MEDICAL CENTER DRIVE
    		CITY:			ROCKVILLE
    		STATE:			MD
    		ZIP:			20850

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	REGENXBIO, Inc.
    		DATE OF NAME CHANGE:	20150116

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	ReGenX Biosciences, LLC
    		DATE OF NAME CHANGE:	20131101
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>rgnx-ars-2024.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: rgnx-ars-2024.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>